Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Tislelizumab Plus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC (RATIONALE 304): A Randomized Phase 3 Trial
PaperCitations, authors & open-access status
Tislelizumab Plus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC (RATIONALE 304): A Randomized Phase 3 Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 284 citations, 2021 year and hybrid oa status.
284
Citations
2021
Year
hybrid
OA Status